Basilea Pharmaceutica AG (BSLN) — Free Cash Flow Generation Index
Basilea Pharmaceutica AG (BSLN) has a Free Cash Flow Generation Index of 0.94x as of December 2025. Free cash flow of CHF36.73 Million represents 1% of operating cash flow (CHF39.03 Million). Explore how much does Basilea Pharmaceutica AG reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Basilea Pharmaceutica AG Free Cash Flow Generation Index (2005–2025)
Historical FCF Generation Index trend for Basilea Pharmaceutica AG across 8 annual periods. For the full cash flow conversion analysis, see BSLN cash flow metrics.
Annual Free Cash Flow Generation for Basilea Pharmaceutica AG (2005–2025)
Year-by-year Free Cash Flow Generation Index for Basilea Pharmaceutica AG. Check BSLN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CHF) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | CHF59.47 Million | CHF62.09 Million | CHF2.62 Million | ▼ -2.0% |
| 2024 | 0.98x | CHF72.65 Million | CHF74.36 Million | CHF1.71 Million | ▲ +5.3% |
| 2023 | 0.93x | CHF13.21 Million | CHF14.24 Million | CHF1.03 Million | ▲ +74.4% |
| 2022 | 0.53x | CHF3.75 Million | CHF7.06 Million | CHF3.30 Million | ▼ -44.7% |
| 2017 | 0.96x | CHF18.30 Million | CHF19.01 Million | CHF711.00K | ▼ -2.9% |
| 2012 | 0.99x | CHF146.85 Million | CHF148.17 Million | CHF1.32 Million | ▲ +0.3% |
| 2010 | 0.99x | CHF105.40 Million | CHF106.64 Million | CHF1.24 Million | ▲ +2.4% |
| 2005 | 0.97x | CHF33.18 Million | CHF34.38 Million | CHF1.20 Million | — |